Max India Limited [MAXIND] vs Indraprastha Medical [INDRAMEDCO] Detailed Stock Comparison
Max India Limited
NSE
Loading...
Indraprastha Medical
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Max India Limited wins in 6 metrics, Indraprastha Medical wins in 12 metrics, with 0 ties. Indraprastha Medical appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Max India Limited | Indraprastha Medical | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -7.13 | 24.13 | Max India Limited |
| Price-to-Book Ratio | 2.63 | 7.00 | Max India Limited |
| Debt-to-Equity Ratio | 28.52 | 5.49 | Indraprastha Medical |
| PEG Ratio | 0.91 | 1.61 | Max India Limited |
| EV/EBITDA | -12.05 | 15.36 | Max India Limited |
| Profit Margin (TTM) | -80.20% | 12.21% | Indraprastha Medical |
| Operating Margin (TTM) | -59.65% | 17.25% | Indraprastha Medical |
| EBITDA Margin (TTM) | N/A | 17.25% | N/A |
| Return on Equity | -39.14% | 26.98% | Indraprastha Medical |
| Return on Assets (TTM) | -22.18% | 18.90% | Indraprastha Medical |
| Free Cash Flow (TTM) | $-1.63B | $1.20B | Indraprastha Medical |
| Dividend Yield | N/A | 0.95% | N/A |
| 1-Year Return | -11.05% | 9.20% | Indraprastha Medical |
| Price-to-Sales Ratio (TTM) | 6.60 | 3.04 | Indraprastha Medical |
| Enterprise Value | $9.46B | $38.89B | Indraprastha Medical |
| EV/Revenue Ratio | 5.45 | 2.83 | Indraprastha Medical |
| Gross Profit Margin (TTM) | 76.14% | 38.19% | Max India Limited |
| Revenue per Share (TTM) | $40 | $150 | Indraprastha Medical |
| Earnings per Share (Diluted) | $-30.09 | $18.86 | Indraprastha Medical |
| Beta (Stock Volatility) | 0.17 | 0.57 | Max India Limited |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Max India Limited vs Indraprastha Medical Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Max India Limited | 0.35% | 1.48% | -0.49% | 15.83% | 15.90% | -21.22% |
| Indraprastha Medical | 1.51% | 3.48% | -3.24% | -7.50% | 14.75% | -14.65% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Max India Limited | -11.05% | 157.53% | 277.19% | 187.86% | 187.86% | 187.86% |
| Indraprastha Medical | 9.20% | 642.22% | 819.28% | 590.66% | 890.15% | 874.50% |
News Based Sentiment: Max India Limited vs Indraprastha Medical
Max India Limited
News based Sentiment: MIXED
September was a mixed month for Max India, with positive developments like a successful fundraising round and asset monetization offset by a declining share price and continued revenue challenges. The strategic relocation adds another layer of complexity, making it a significant month for investors to assess the company's direction.
Indraprastha Medical
News based Sentiment: MIXED
September presented a mixed bag for Indraprastha Medical, with slightly disappointing Q2 results countered by a consistent dividend and an attractive valuation. While profitability declined, the company maintains a commitment to shareholder returns and appears undervalued compared to its peers, creating a complex investment picture.
Performance & Financial Health Analysis: Max India Limited vs Indraprastha Medical
| Metric | MAXIND | INDRAMEDCO |
|---|---|---|
| Market Information | ||
| Market Cap | ₹11.92B | ₹42.43B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 597,405 | 115,470 |
| 90 Day Avg. Volume | 227,859 | 212,862 |
| Last Close | ₹218.77 | ₹462.40 |
| 52 Week Range | ₹169.00 - ₹320.69 | ₹307.25 - ₹572.00 |
| % from 52W High | -31.78% | -19.16% |
| All-Time High | ₹338.00 (Jul 08, 2024) | ₹572.00 (Jan 06, 2025) |
| % from All-Time High | -35.28% | -19.16% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.29% | 0.05% |
| Quarterly Earnings Growth | N/A | 0.15% |
| Financial Health | ||
| Profit Margin (TTM) | -0.80% | 0.12% |
| Operating Margin (TTM) | -0.60% | 0.17% |
| Return on Equity (TTM) | -0.39% | 0.27% |
| Debt to Equity (MRQ) | 28.52 | 5.49 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹83.04 | ₹65.04 |
| Cash per Share (MRQ) | ₹39.83 | ₹35.08 |
| Operating Cash Flow (TTM) | ₹-1,558,828,000 | ₹1.78B |
| Levered Free Cash Flow (TTM) | ₹-1,403,920,000 | ₹1.61B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.95% |
| Last 12-Month Dividend | N/A | ₹4.50 |
Valuation & Enterprise Metrics Analysis: Max India Limited vs Indraprastha Medical
| Metric | MAXIND | INDRAMEDCO |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -7.13 | 24.13 |
| Forward P/E | N/A | 182.00 |
| PEG Ratio | 0.91 | 1.61 |
| Price to Sales (TTM) | 6.60 | 3.04 |
| Price to Book (MRQ) | 2.63 | 7.00 |
| Market Capitalization | ||
| Market Capitalization | ₹11.92B | ₹42.43B |
| Enterprise Value | ₹9.46B | ₹38.89B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 5.45 | 2.83 |
| Enterprise to EBITDA | -12.05 | 15.36 |
| Risk & Other Metrics | ||
| Beta | 0.17 | 0.57 |
| Book Value per Share (MRQ) | ₹83.04 | ₹65.04 |
Financial Statements Comparison: Max India Limited vs Indraprastha Medical
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | MAXIND | INDRAMEDCO |
|---|---|---|
| Revenue/Sales | ₹366.70M | ₹3.65B |
| Cost of Goods Sold | ₹87.50M | ₹2.26B |
| Gross Profit | ₹279.20M | ₹1.39B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹-336.20M | ₹629.70M |
| EBITDA | ₹-232.50M | ₹800.50M |
| Pre-Tax Income | ₹-246.60M | ₹683.10M |
| Income Tax | ₹9.80M | ₹168.50M |
| Net Income (Profit) | ₹-256.40M | ₹514.60M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | MAXIND | INDRAMEDCO |
|---|---|---|
| Cash & Equivalents | ₹226.95M | ₹614.80M |
| Total Current Assets | ₹2.61B | ₹4.31B |
| Total Current Liabilities | ₹1.65B | ₹1.79B |
| Long-Term Debt | ₹958.90M | ₹305.40M |
| Total Shareholders Equity | ₹3.59B | ₹5.97B |
| Retained Earnings | ₹-2.24B | ₹4.75B |
| Property, Plant & Equipment | ₹1.53B | ₹2.60B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | MAXIND | INDRAMEDCO |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | MAXIND | INDRAMEDCO |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 597,405 | 115,470 |
| Average Daily Volume (90 Day) | 227,859 | 212,862 |
| Shares Outstanding | 46.15M | 91.67M |
| Float Shares | 25.48M | 41.01M |
| % Held by Insiders | 0.60% | 0.58% |
| % Held by Institutions | 0.00% | 0.03% |
Dividend Analysis & Yield Comparison: Max India Limited vs Indraprastha Medical
| Metric | MAXIND | INDRAMEDCO |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹4.50 |
| Last 12-Month Dividend Yield | N/A | 0.95% |
| 3-Year Avg Annual Dividend | N/A | ₹4.00 |
| 3-Year Avg Dividend Yield | N/A | 1.26% |
| 3-Year Total Dividends | N/A | ₹12.00 |
| Ex-Dividend Date | N/A | Sep 18, 2025 |